Dyslipidemia in the metabolic syndrome in children.
The high triglyceride/low high-density lipoprotein cholesterol phenotype is a component of the metabolic syndrome. The obesity epidemic has increased the prevalence of this abnormality. Recognition of this dyslipidemia is increasingly common in pediatric practice. Treatment includes weight management, including the prevention of future excess weight gain, and exercise. Pharmacologic management is rarely required.
Gidding
Samuel S
SS
A. I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19899, USA. sgidding@nemours.org
D000293:Adolescent; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D002648:Child; D008076:Cholesterol, HDL / Q000097:blood; D003920:Diabetes Mellitus / Q000097:blood / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D004032:Diet; D050171:Dyslipidemias / Q000097:blood / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D015444:Exercise; D015438:Health Behavior; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008019:Life Style; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D009765:Obesity / Q000097:blood / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D014280:Triglycerides